SEC Company Response from TuHURA Biosciences, (HURA) — Jul 1, 2015
TuHURA Biosciences, Inc./NV (HURA) (CIK 0001498382)
Date: July 1, 2015 · CIK: 0001498382 · Accession: 0001013762-15-000672
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-203357
Letter
Re: DelMar Pharmaceuticals, Inc.
July 1,
Securities and Exchange Commission
100 F. Street, NE
Washington, D.C. 20549
Registration Statement on Form S-1
File No. 333-203357
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended, Maxim Group LLC and Roth Capital Partners, LLC, as co-lead placement agents, hereby request acceleration of the effective date of the above-referenced Registration Statement so that it will become effective at 1:00 p.m., Washington D.C. time, on Thursday, July 2, 2015, or as soon thereafter as practicable.
The following is supplemental information supplied under Rule 418(a)(7) and Rule 460 under the Securities Act of 1933:
(i) Date of preliminary prospectus: June 12, 2015
(ii) Dates of distribution: June 12, 2015 – June 23, 2015
(iii) Number of prospective underwriters and dealers to whom the preliminary prospectus was furnished: 5
(iv) Number of prospectuses so distributed: approximately: 459
The undersigned confirms that it has complied with and will continue to comply with, and it has been informed or will be informed by participating dealers that they have complied with or will comply with, Rule 15c2-8 promulgated under the Securities Exchange Act of 1934, as amended, in connection with the above-referenced issue.
Very truly
yours,
MAXIM
GROUP LLC
Show Raw Text
CORRESP
1
filename1.htm
July 1,
2015
Securities
and Exchange Commission
100 F. Street,
NE
Washington,
D.C. 20549
Re: DelMar
Pharmaceuticals, Inc.
Registration
Statement on Form S-1
File
No. 333-203357
Ladies and
Gentlemen:
Pursuant
to Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933,
as amended, Maxim Group LLC and Roth Capital Partners, LLC, as co-lead placement agents, hereby request acceleration of the effective
date of the above-referenced Registration Statement so that it will become effective at 1:00 p.m., Washington D.C. time, on Thursday,
July 2, 2015, or as soon thereafter as practicable.
The following
is supplemental information supplied under Rule 418(a)(7) and Rule 460 under the Securities Act of 1933:
(i)
Date
of preliminary prospectus: June 12, 2015
(ii)
Dates of distribution: June
12, 2015 – June 23, 2015
(iii)
Number of prospective
underwriters and dealers to whom the preliminary prospectus was furnished: 5
(iv)
Number of prospectuses
so distributed: approximately: 459
The undersigned
confirms that it has complied with and will continue to comply with, and it has been informed or will be informed by participating
dealers that they have complied with or will comply with, Rule 15c2-8 promulgated under the Securities Exchange Act of 1934, as
amended, in connection with the above-referenced issue.
Very truly
yours,
MAXIM
GROUP LLC
/s/ Clifford
A. Teller
Name: Clifford
A. Teller
Title: Executive
Managing Director,
Head
of Investment Banking
ROTH
CAPITAL PARTNERS, LLC
/s/ Aaron
M. Gurewitz
Name: Aaron
M. Gurewitz
Title: Head
of Equity Capital Markets